Fundic Gland Polyps in the Pediatric Population: Clinical and Histopathologic Studies

We retrospectively studied the clinical and histologic features of pediatric fundic gland polyps (FGPs) in 16 patients. FGPs had an endoscopic prevalence of 0.25% in 8527 pediatric gastric biopsies. Five patients had familial adenomatous polyposis (FAP). The median age of onset was 17.7 years in FAP and 17.3 years in sporadic patients. All syndromic patients were asymptomatic and FGPs were identified during surveillance for existing or concurrent colon polyps. They did not take antacids. In comparison, all 11 sporadic FGPs were identified during evaluation of symptomatic patients who had taken antacids (median duration 21 months). Syndromic FGPs can be multiple at single endoscopy and were more likely to recur, while sporadic FGPs were often single. None of the sporadic patients had recurrence of FGPs or a subsequent diagnosis of FAP during a median follow-up of 20.5 months. The dilated fundic glands were lined by parietal and chief cells only in a majority (22/41, 53.7%) of syndromic FGPs, while additional tall mucinous lining cells were found in all sporadic FGPs. Syndromic FGPs did not have parietal cell hypertrophy in the background oxyntic mucosa. Nuclear immunopositivity for beta-catenin was essentially absent in all the FGPs. In conclusion, FGPs were rare in pediatric patients. In syndromic patients, FGPs are asymptomatic and did not precede colon polyps. Prolonged antacid intake seems to be associated with development of sporadic FGPs. Cellular components of dilated fundic glands and background parietal cell hypertrophy can be useful features to eliminate concern for syndromic polyposis.

[1]  B. Bhattacharya,et al.  Sporadic Fundic Gland Polyps With Low-Grade Dysplasia: A Large Case Series Evaluating Pathologic and Immunohistochemical Findings and Clinical Behavior. , 2015, American journal of clinical pathology.

[2]  A. Sonnenberg,et al.  Prevalence of benign gastric polyps in a large pathology database. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[3]  B. Weiss,et al.  Polyposis syndromes in children and adolescents: a case series data analysis , 2014, European journal of gastroenterology & hepatology.

[4]  R. Kitazawa,et al.  Duodenal gastric heterotopia, sporadic or fundic gland polyp-associated, frequently carries β-catenin mutation , 2014, Virchows Archiv.

[5]  Hyojin Park,et al.  A Novel Germline Mutation in Exon 15 of the APC Gene in Attenuated Familial Adenomatous Polyposis: A Report of Two Cases , 2013, Gut and liver.

[6]  C. Ell,et al.  Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5‐year follow‐up in the LOTUS trial , 2012, Alimentary pharmacology & therapeutics.

[7]  R. Wong,et al.  Chronic Proton Pump Inhibitor Therapy Associated with Increased Development of Fundic Gland Polyps , 2009, Digestive Diseases and Sciences.

[8]  H. Boezen,et al.  Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy , 2006, Alimentary pharmacology & therapeutics.

[9]  J. Stoner,et al.  Multicenter Experience with Upper Gastrointestinal Polyps in Pediatric Patients with Familial Adenomatous Polyposis , 2004, American Journal of Gastroenterology.

[10]  S. Xiao,et al.  Immunohistochemical evaluation of adenomatous polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps. , 2004, Human pathology.

[11]  D. Rex,et al.  Positive Predictive Value of Endoscopic Features Deemed Typical of Gastric Fundic Gland Polyps , 2003, Journal of clinical gastroenterology.

[12]  Tsung-Teh Wu,et al.  Sporadic Fundic Gland Polyposis: A Clinical, Histological, and Molecular Analysis , 2002, Modern Pathology.

[13]  I. Tomlinson,et al.  Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. , 2002, The American journal of pathology.

[14]  S. Hirohashi,et al.  β-Catenin mutations in sporadic fundic gland polyps , 2002, Virchows Archiv.

[15]  T. Attard,et al.  Gastric polyps in pediatrics: an 18-year hospital-based analysis. , 2002 .

[16]  J. Church,et al.  Attenuated Familial Adenomatous Polyposis , 2002, Diseases of the colon and rectum.

[17]  M. Vieth,et al.  Fundic gland polyps are not induced by proton pump inhibitor therapy. , 2001, American journal of clinical pathology.

[18]  S. Hamilton,et al.  Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. , 2001, The American journal of pathology.

[19]  F. Giardiello,et al.  Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. , 2000, The American journal of pathology.

[20]  R. Riddell,et al.  Omeprazole produces parietal cell hypertrophy and hyperplasia in humans , 1996, Digestive diseases and sciences.

[21]  M. Stolte,et al.  Frequency, Location, and Age and Sex Distribution of Various Types of Gastric Polyp , 1994, Endoscopy.

[22]  M. El‐Youssef,et al.  The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes. , 2014, Journal of pediatric surgery.

[23]  J. Stockman.  Familial Adenomatous Polyposis in Children and Adolescents , 2012 .

[24]  H. Hollema,et al.  Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates. , 2003, Scandinavian journal of gastroenterology.

[25]  S. Hirohashi,et al.  Beta-catenin mutations in sporadic fundic gland polyps. , 2002, Virchows Archiv : an international journal of pathology.